{"entity":{"type":"insider","cik":"0001617236","url":"/insider/0001617236","json_url":"/insider/0001617236.json","name":"Levine Mark S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":23,"first":"2017-01-06","last":"2024-11-22","span_basis":"filed_date"},"name_variants":[{"name":"Levine Mark S.","source":"filing","n_filings":23,"first_seen":"2017-01-06","last_seen":"2024-11-22"}],"transactions":[{"id":2873679,"accession":"0001764013-24-000196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000196","line_url":"/filing/0001764013-24-000196#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3650.0,"shares_display":"3,650","price_per_share":25.45,"price_display":"25.45","price_state":"stated","total_value":92892.5,"total_display":"92,892.50","total_whole":"92,893","shares_owned_after":319228.0,"shares_owned_after_display":"319,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2050432,"accession":"0001764013-24-000180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000180","line_url":"/filing/0001764013-24-000180#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4361.0,"shares_display":"4,361","price_per_share":29.53,"price_display":"29.53","price_state":"stated","total_value":128780.33,"total_display":"128,780.33","total_whole":"128,780","shares_owned_after":322878.0,"shares_owned_after_display":"322,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-23","filed_date":"2024-10-25","scope":"insider"},{"id":2832132,"accession":"0001764013-24-000172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000172","line_url":"/filing/0001764013-24-000172#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2860.0,"shares_display":"2,860","price_per_share":28.79,"price_display":"28.79","price_state":"stated","total_value":82339.4,"total_display":"82,339.40","total_whole":"82,339","shares_owned_after":327239.0,"shares_owned_after_display":"327,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2972274,"accession":"0001764013-24-000160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000160","line_url":"/filing/0001764013-24-000160","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3295.0,"shares_display":"3,295","price_per_share":31.859083459787556,"price_display":"31.86","price_state":"stated","total_value":104975.68,"total_display":"104,975.68","total_whole":"104,976","shares_owned_after":330230.0,"shares_owned_after_display":"330,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider","n_lines":2},{"id":2925388,"accession":"0001764013-24-000141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000141","line_url":"/filing/0001764013-24-000141#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4015.0,"shares_display":"4,015","price_per_share":27.76,"price_display":"27.76","price_state":"stated","total_value":111456.4,"total_display":"111,456.40","total_whole":"111,456","shares_owned_after":333394.0,"shares_owned_after_display":"333,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-26","scope":"insider"},{"id":2802878,"accession":"0001764013-24-000137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000137","line_url":"/filing/0001764013-24-000137","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2505.0,"shares_display":"2,505","price_per_share":29.69340119760479,"price_display":"29.69","price_state":"stated","total_value":74381.97,"total_display":"74,381.97","total_whole":"74,382","shares_owned_after":337556.0,"shares_owned_after_display":"337,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider","n_lines":2},{"id":2925371,"accession":"0001764013-24-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000095","line_url":"/filing/0001764013-24-000095#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3242.0,"shares_display":"3,242","price_per_share":29.65,"price_display":"29.65","price_state":"stated","total_value":96125.3,"total_display":"96,125.30","total_whole":"96,125","shares_owned_after":339914.0,"shares_owned_after_display":"339,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-24","scope":"insider"},{"id":2747766,"accession":"0001764013-24-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000085","line_url":"/filing/0001764013-24-000085#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3963.0,"shares_display":"3,963","price_per_share":28.9,"price_display":"28.90","price_state":"stated","total_value":114530.7,"total_display":"114,530.70","total_whole":"114,531","shares_owned_after":343156.0,"shares_owned_after_display":"343,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-24","filed_date":"2024-04-26","scope":"insider"},{"id":3272513,"accession":"0001764013-24-000083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000083","line_url":"/filing/0001764013-24-000083","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9827.0,"shares_display":"9,827","price_per_share":29.058115396356975,"price_display":"29.06","price_state":"stated","total_value":285554.1,"total_display":"285,554.10","total_whole":"285,554","shares_owned_after":349344.0,"shares_owned_after_display":"349,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-04-19","scope":"insider","n_lines":2},{"id":2050422,"accession":"0001764013-24-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000040","line_url":"/filing/0001764013-24-000040#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2134.0,"shares_display":"2,134","price_per_share":36.15,"price_display":"36.15","price_state":"stated","total_value":77144.1,"total_display":"77,144.10","total_whole":"77,144","shares_owned_after":301968.0,"shares_owned_after_display":"301,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-23","scope":"insider"},{"id":2572728,"accession":"0001764013-24-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000018","line_url":"/filing/0001764013-24-000018","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3027.0,"shares_display":"3,027","price_per_share":37.91820614469772,"price_display":"37.92","price_state":"stated","total_value":114778.41,"total_display":"114,778.41","total_whole":"114,778","shares_owned_after":304148.0,"shares_owned_after_display":"304,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-29","scope":"insider","n_lines":2},{"id":8489848,"accession":"0001764013-23-000137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000137","line_url":"/filing/0001764013-23-000137","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3252.0,"shares_display":"3,252","price_per_share":32.77936039360394,"price_display":"32.78","price_state":"stated","total_value":106598.48,"total_display":"106,598.48","total_whole":"106,598","shares_owned_after":307253.0,"shares_owned_after_display":"307,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-24","scope":"insider","n_lines":2},{"id":7911394,"accession":"0001764013-23-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000125","line_url":"/filing/0001764013-23-000125#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4107.0,"shares_display":"4,107","price_per_share":34.66,"price_display":"34.66","price_state":"stated","total_value":142348.62,"total_display":"142,348.62","total_whole":"142,349","shares_owned_after":310381.0,"shares_owned_after_display":"310,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-25","filed_date":"2023-10-27","scope":"insider"},{"id":8008218,"accession":"0001764013-23-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000105","line_url":"/filing/0001764013-23-000105","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12286.0,"shares_display":"12,286","price_per_share":20.30004802213902,"price_display":"20.30","price_state":"stated","total_value":249406.39,"total_display":"249,406.39","total_whole":"249,406","shares_owned_after":314489.0,"shares_owned_after_display":"314,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-25","scope":"insider","n_lines":2},{"id":7984691,"accession":"0001764013-23-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000084","line_url":"/filing/0001764013-23-000084#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3917.0,"shares_display":"3,917","price_per_share":21.63,"price_display":"21.63","price_state":"stated","total_value":84724.71,"total_display":"84,724.71","total_whole":"84,725","shares_owned_after":326774.0,"shares_owned_after_display":"326,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-26","filed_date":"2023-07-27","scope":"insider"},{"id":8307351,"accession":"0001764013-23-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000059","line_url":"/filing/0001764013-23-000059#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2633.0,"shares_display":"2,633","price_per_share":16.29,"price_display":"16.29","price_state":"stated","total_value":42891.57,"total_display":"42,891.57","total_whole":"42,892","shares_owned_after":330691.0,"shares_owned_after_display":"330,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-26","scope":"insider"},{"id":7984685,"accession":"0001764013-23-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000015","line_url":"/filing/0001764013-23-000015#line-1","is_derivative":false,"issuer_cik":"0001617236","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001617236","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10156.0,"shares_display":"10,156","price_per_share":18.51,"price_display":"18.51","price_state":"stated","total_value":187987.56,"total_display":"187,987.56","total_whole":"187,988","shares_owned_after":245660.0,"shares_owned_after_display":"245,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-26","filed_date":"2023-01-27","scope":"insider"},{"id":5381303,"accession":"0001209191-21-047502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-047502","line_url":"/filing/0001209191-21-047502#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3945.0,"shares_display":"3,945","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":25445.25,"total_display":"25,445.25","total_whole":"25,445","shares_owned_after":133486.0,"shares_owned_after_display":"133,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-20","scope":"insider"},{"id":5543871,"accession":"0001209191-21-002559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-002559","line_url":"/filing/0001209191-21-002559#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6829.0,"shares_display":"6,829","price_per_share":11.13,"price_display":"11.13","price_state":"stated","total_value":76006.77,"total_display":"76,006.77","total_whole":"76,007","shares_owned_after":107431.0,"shares_owned_after_display":"107,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-07","scope":"insider"},{"id":2528606,"accession":"0001209191-20-002285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002285","line_url":"/filing/0001209191-20-002285#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3724.0,"shares_display":"3,724","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":43487.0,"shares_owned_after_display":"43,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-07","scope":"insider"},{"id":8003148,"accession":"0001209191-19-002087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-002087","line_url":"/filing/0001209191-19-002087#line-1","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":734.0,"shares_display":"734","price_per_share":12.36,"price_display":"12.36","price_state":"stated","total_value":9072.24,"total_display":"9,072.24","total_whole":"9,072","shares_owned_after":9060.0,"shares_owned_after_display":"9,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":4905403,"accession":"0001209191-17-037738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-037738","line_url":"/filing/0001209191-17-037738#line-2","is_derivative":false,"issuer_cik":"0001598646","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001598646","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (SVP,General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (SVP,General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,General Counsel & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":192500.0,"total_display":"192,500.00","total_whole":"192,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-05","scope":"insider"},{"id":5340736,"accession":"0001209191-17-002652","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-002652","line_url":"/filing/0001209191-17-002652#line-3","is_derivative":false,"issuer_cik":"0001598646","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001598646","owner_cik":"0001617236","owner_name":"Levine Mark S.","owner_display_name":"Levine Mark S.","owner_url":"/insider/0001617236","role":"Officer (SVP,General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (SVP,General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,General Counsel & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":210000.0,"total_display":"210,000.00","total_whole":"210,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Officer (Chief Legal Officer)","n_filings":17,"first_seen":"2023-01-27","last_seen":"2024-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Officer (General Counsel)","n_filings":4,"first_seen":"2019-01-04","last_seen":"2021-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001598646","name":"Minerva Neurosciences, Inc.","url":"/issuer/0001598646","role":"Officer (SVP,General Counsel & Sec)","n_filings":2,"first_seen":"2017-01-06","last_seen":"2017-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001617236","retrieved_at":"2026-08-22T10:10:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}